Episode 182 - Stopping neurodegenerative diseases in their tracks - Howard Berman of Coya Therapeutics

Howard Berman is the CEO and co-founder of Coya Therapeutics, a company that’s developed a treatment to prevent the spreading of neurodegenerative diseases like dementia and ALS. The company went public a few months ago, and Howard shares what it’s been like leading the commercialization of a company with so much potential to save lives.